Search Within

Matthew J Matasar

  1. "Bone Marrow Transplant"
  2. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (4)
Groups
  1. Bone Marrow Transplant (16)
  2. Center for Hematologic Malignancies (16)
  3. Department of Medicine (16)
  4. Hematologic Malignancies, Division of (16)
  5. Lymphoma (16)
  6. Sloan Kettering Institute Postdocs (16)

More Groups

People
  1. Paul Hamlin (14)
  2. Andrew Zelenetz (13)
  3. Anita Kumar (13)
  4. Ariela Noy (13)
  5. David Straus (13)
  6. Steven Horwitz (13)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (2)
  4. 2019 (3)
  5. 2018 (1)
  6. 2017 (4)

More Years

Publications
  1. Blood (9)
  2. Blood Advances (2)
  3. Hematological Oncology (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Journal of Clinical Oncology (1)
  6. Neuro-Oncology (1)
Publishers
  1. American Society of Hematology (11)
  2. Wiley Blackwell (2)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Inc. (1)
  5. Oxford University Press (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of PET staging of follicular lymphoma on treatment outcomes and prognosis
    Meeting Abstract

    Alperovich, A.; Batlevi, C. L.; Intlekofer, A. M.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, A. J.; Gerecitano, J.; Hamlin, P. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
    Journal Article

    Thomas, A. A.; Abrey, L. E.; Terziev, R.; Raizer, J.; Martinez, N. L.; Forsyth, P.; Paleologos, N.; Matasar, M.; Sauter, C. S.; Moskowitz, C.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Ni, A.; Soumerai, J.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save